BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2991640)

  • 1. Influence of polymeric effectors on binding of 3H-dihydroalprenolol to beta-adrenergic receptor of rat brain.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 May; 38(1):17-23. PubMed ID: 2991640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding characteristics of 3H-dihydroalprenolol to beta-adrenergic receptors of rat brain: influence of lectins.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 Jun; 38(2):121-5. PubMed ID: 2993717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of 3H-dihydroalprenolol to beta-adrenergic receptors of rat brain: influence of exo- and endo-glycosidases and glycopeptidase.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 Aug; 38(4):403-9. PubMed ID: 2999487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding characteristics of 3H-dihydroalprenolol to beta-adrenoceptors of rat heart treated with neuraminidase.
    Nagatomo T; Sasaki M; Tsuchihashi H; Imai S
    Jpn J Pharmacol; 1983 Aug; 33(4):851-7. PubMed ID: 6314011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the (--)-[3H]-dihydroalprenolol binding to beta-adrenoceptors and transmembrane 86Rb efflux of the BC3H1 nonfusing muscle cell line.
    Mauger JP; Worcel M
    Br J Pharmacol; 1980 Apr; 68(4):731-9. PubMed ID: 6103725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics of [3H]dihydroalprenolol to beta-adrenergic receptors of rat brain: comparison with those of rat heart treated with neuraminidase.
    Tsuchihashi H; Sasaki M; Nagatomo T
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3972-6. PubMed ID: 3004753
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]dihydroalprenolol binding in the rat brainstem.
    Stone EA; U'Prichard DC
    Eur J Pharmacol; 1981 Oct; 75(2-3):159-61. PubMed ID: 6119217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
    Landi M; Bianchetti A; Croci T; Manara L
    Biochem Pharmacol; 1992 Aug; 44(4):665-72. PubMed ID: 1354964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA; Kellar KJ
    Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of 3H-dihydroalprenolol to beta-adrenoceptors in adipocytes of spontaneously hypertensive rats and essentially hypertensive patients.
    Boriskina GM; Postnov YuV
    Experientia; 1982 Feb; 38(2):263-4. PubMed ID: 6277685
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.
    Chang RS; Lotti VJ
    Life Sci; 1983 May; 32(22):2603-9. PubMed ID: 6134224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta 1-Adrenergic receptors in kidney tubular cell membrane in the rat.
    Gavendo S; Kapuler S; Serban I; Iaina A; Ben-David E; Eliahou H
    Kidney Int; 1980 Jun; 17(6):764-70. PubMed ID: 6251307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of skeletal muscle beta-adrenergic receptors coupled to adenylate cyclase.
    Reddy NB; Engel WK
    Biochim Biophys Acta; 1979 Jul; 585(3):343-59. PubMed ID: 226166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic receptors in guinea-pig liver plasma membranes and thermal lability of [3H]dihydroalprenolol binding sites.
    Kawai Y; Graham SM; Yoshioka H; Arinze IJ
    Biochem Pharmacol; 1986 Dec; 35(24):4387-93. PubMed ID: 3024648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine.
    Kinnier WJ; Chuang DM; Costa E
    Eur J Pharmacol; 1980 Oct; 67(2-3):289-94. PubMed ID: 6257531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of beta 1- and beta 2-adrenoceptors in the rabbit heart: quantitative analysis of the regional distribution by (-)-3H-dihydroalprenolol binding.
    Brodde OE; Leifert FJ; Krehl HJ
    J Cardiovasc Pharmacol; 1982; 4(1):34-43. PubMed ID: 6176797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of functionally active beta-adrenoceptors in rat mast cells. Correlation between (--)[3H]-dihydroalprenolol binding and inhibition of histamine release.
    Masini E; Fantozzi R; Blandina P; Galli A; Bani-Sacchi T; Giotti A; Zilletti L; Mannaioni PF
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):171-6. PubMed ID: 6185855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of 3H-dihydroalprenolol binding to beta-adrenergic receptors of rat brain: two binding sites of racemic propranolol in displacement experiments.
    Tsuchihashi H; Nagatomo T
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2979-84. PubMed ID: 2824078
    [No Abstract]   [Full Text] [Related]  

  • 20. [3H]Dihydroalprenolol binding sites in rat myocardium: relationship between a single binding site population and the concentration of radioligand.
    Winek R; Bhalla R
    Biochem Biophys Res Commun; 1979 Nov; 91(1):200-6. PubMed ID: 229841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.